No elevated risk for depression, anxiety or suicidality with secukinumab in a pooled analysis of data from 10 clinical studies in moderate-to-severe plaque psoriasis

2017 ◽  
Vol 178 (2) ◽  
pp. e105-e107 ◽  
Author(s):  
B.E. Strober ◽  
R.G.B. Langley ◽  
A. Menter ◽  
M. Magid ◽  
B. Porter ◽  
...  
Keyword(s):  
Plaque Psoriasis ◽  
Clinical Studies ◽  
Pooled Analysis ◽  
Elevated Risk ◽  
Severe Plaque Psoriasis ◽  
Risk For Depression

Secukinumab long-term safety experience: A pooled analysis of 10 phase II and III clinical studies in patients with moderate to severe plaque psoriasis

2016 ◽  
Vol 75 (1) ◽  
pp. 83-98.e4 ◽  
Author(s):  
Peter C.M. van de Kerkhof ◽  
Christopher E.M. Griffiths ◽  
Kristian Reich ◽  
Craig L. Leonardi ◽  
Andrew Blauvelt ◽  
...  
Keyword(s):  
Phase Ii ◽  
Plaque Psoriasis ◽  
Clinical Studies ◽  
Pooled Analysis ◽  
Severe Plaque Psoriasis ◽  
Phase Ii And Iii

scholarly journals Secukinumab is Efficacious and Safe in Hispanic Patients with Moderate-to-Severe Plaque Psoriasis: Pooled Analysis of Four Phase 3 Trials

2017 ◽  
Vol 34 (6) ◽  
pp. 1327-1339 ◽  
Author(s):  
Sandra Adsit ◽  
Enrique Rivas Zaldivar ◽  
Howard Sofen ◽  
Ignacio Dei-Cas ◽  
César Maldonado-García ◽  
...  
Keyword(s):  
Plaque Psoriasis ◽  
Pooled Analysis ◽  
Phase 3 ◽  
Severe Plaque Psoriasis ◽  
Hispanic Patients
Sign in / Sign up

Export Citation Format

Share Document